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Abstract Recessive mutations in chromosome 10 open read-
ing frame 2 (C10orf2) are relevant in infantile-onset
spinocerebellar ataxia (IOSCA). In this study, we investigated
the causative mutation in a Korean family with combined
phenotypes of IOSCA, sensorimotor polyneuropathy, and
myopathy. We investigated recessive mutations in a Korean
family with two individuals affected by IOSCA. Causative
mutations were investigated using whole exome sequencing.
Electrophysiological analyses and muscle and nerve biopsies
were performed, along with magnetic resonance imaging
(MRI) of the brain and lower extremities. Compound hetero-
zygous mutations c.1460C>T and c.1485-1G>A in C10orf2
were identified as causative of IOSCA. Skeletal muscle
showed mitochondrial DNA (mtDNA) deletions. Both pa-
tients showed a period of normal development until 12–
15 months, followed by ataxia, athetosis, hearing loss, and
intellectual disability. Electrophysiological findings indicated
motor and sensory polyneuropathies. Muscle biopsy revealed
variations in the size and shape of myofibers with scattered,
small, and angulated degenerating myofibers containing ab-
normal mitochondria; these observations are consistent with
myopathy and may be the result of mtDNA deletions. Sural
nerve biopsy revealed an axonal neuropathy. High-signal-
intensity lesions in the middle cerebellar peduncles were
correlated with clinical severity, and MRI of the lower legs
was compatible with the hypothesis of length-dependent axo-
nal degeneration. We identified novel compound heterozy-
gous mutations of the C10orf2 gene as the cause of IOSCA
with sensorimotor polyneuropathy and myopathy. Signs of
motor neuropathy and myopathy were discovered for the first
time in IOSCA patients with C10orf2 mutations. These re-
sults suggest that the clinical spectrum of IOSCA
caused by C10orf2 mutations may be more variable
than previously reported.
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Mutations in nuclear genes involved in mitochondrial DNA
(mtDNA) maintenance are increasingly associated with a
wide range of clinical phenotypes including encephalopathy,
progressive external ophthalmoplegia (PEO), ataxia, myopa-
thy, and Parkinson’s disease [1, 2]. Mutations in DNA poly-
merase gamma (POLG), DNA helicase Twinkle (C10orf2), or
mitochondrial transcription factor A (TFAM) have been linked
to the deterioration of mtDNA [3].
Chromosome 10 open reading frame 2 (C10orf2), also
known as Twinkle or PEO1, encodes the mitochondrial
helicase Twinkle. Defects inC10orf2 lead to the accumulation
of multiple deletions in the mtDNA of affected tissues and an
associated respiratory chain defect [4]. Mutations in the
C10orf2 gene have been shown to play a role in multiple
autosomal recessive diseases including infantile-onset
spinocerebellar ataxia (IOSCA), hepatocerebral syndrome,
and autosomal dominant PEO (adPEO) [5]. However, it re-
mains unclear why some autosomal recessive mutations result
in IOSCAwhile others cause hepatocerebral syndrome.
The clinical symptoms of IOSCA (OMIM# 271245) are
characterized by a period of normal development, followed by
onset of ataxia, hypotonia, loss of deep tendon reflexes, and
athetosis between 9 and 18 months [6]. Later stages of disease
are characterized by ophthalmoparesis, sensorineural hearing
loss, epilepsy, and primary hypogonadism in female patients.
Electromyographic findings are characterized by axonal sen-
sory neuropathy; however, no reports exist describing an
IOSCA patient harboring motor neuropathy [5–7]. Although
adPEO patients with C10orf2 mutations usually demonstrate
mtDNA deletions in muscle [8, 9], IOSCA patients show no
signs of mtDNA deletion. Muscle biopsies of IOSCA patients
revealed only nonspecific fiber-type groupings [5–7, 10]. In
contrast to the more well-described adPEO, a limited number
of reports have been written on IOSCA.
We report the clinical, histopathological, and genetic de-
fects observed with IOSCA, sensorimotor polyneuropathy,
and myopathy, which were associated with novel compound
heterozygous mutations in C10orf2.
Materials and methods
Subjects
This study examined four members of a Korean family (fam-
ily ID: FC417), two of whom were affected by IOSCA
(Fig. 1a). Phenotypic analysis of this family suggested an
autosomal recessive mode of inheritance as both children
exhibited symptoms of the disease, while both parents were
unaffected. No affected individuals were identified among
close relatives of the family. Written informed consent was
obtained from all participants and from a parent of the partic-
ipants younger than 18 years of age, according to the protocol
approved by the Institutional Review Board of EwhaWomans
University, Mokdong Hospital, and the Korea National Insti-
tutes of Health (KNIH).
Clinical and electrophysiological assessments
Two independent neurologists evaluated the patients by re-
cording a detailed history of motor and sensory impairments,
deep tendon reflexes, and muscle atrophy. Flexor and extensor
muscle strength were assessed manually using the Medical
Research Council (MRC) scale. To determine physical dis-
ability, we used two scales, a functional disability scale (FDS)
[11] and a Charcot–Marie–Tooth neuropathy score (CMTNS)
[12]. Disease severity was determined for each patient using a
nine-point FDS. Sensory impairments were assessed in terms
of the magnitude and severity of pain, temperature, vibration,
and position perceptions.
Nerve conduction studies (NCSs) were performed using
surface electrodes in the median, ulnar, peroneal, tibial, and
sural nerves. Motor nerve conduction velocities (MNCVs) of
the median and ulnar nerves were determined by providing
stimulation at the elbow and wrist while recording compound
muscle action potentials (CMAPs) over the abductor pollicis
brevis and adductor digiti quinti, respectively. In the same
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manner, the MNCVs of the peroneal and tibial nerves were
determined by stimulation at the knee and ankle while record-
ing CMAPs over the extensor digitorum brevis and adductor
hallucis, respectively. Sensory nerve conduction velocities
(SNCVs) were obtained over a finger–wrist segment from
the median and ulnar nerves by orthodromic scoring; SNCVs
were also recorded for sural nerves. Needle electromyography
(EMG) was performed on bilateral proximal and distal limb
muscles of the upper and lower extremities. Visual evoked
potentials and brainstem auditory evoked potentials in two
patients (II-1 and II-2) were done.
Vastus lateralis muscle biopsy
Histopathological analysis of the skeletal muscle was per-
formed on a 21-year-old patient (patient II-2). The muscle
biopsy was taken from the left vastus lateralis muscle under
local anesthesia. Frozen sections were stained with hematox-
ylin and eosin and Gomori’s trichrome stain and for nicotin-
amide adenine dinucleotide (NADH)-tetrazolium reductase
(NADH-TR), succinate dehydrogenase (SDH), and
cytochrome oxidase (COX). Adenosine triphosphatase
(ATPase) activity was assessed under different pH conditions
(ATPase at pH 9.4 followed by preincubation at pH 4.6 and
4.3). An ultrastructural analysis was also performed.
Distal sural nerve biopsy
Histopathological analysis of the distal sural nerve biopsy was
performed at 19 years of age (patient II-2). In addition to light
microscopic examination, electron microscopic observations
were made using specimens fixed in 2 % glutaraldehyde in
0.025 M cacodylate buffer (pH 7.4) and processed for semi-
thin and ultra-thin studies. Semi-thin sections were stained
with toluidine blue for evaluation by light microscopy. Ultra-
thin sections (60–65 nm) were contrasted with uranyl acetate
and lead citrate for ultrastructural studies (H-7650, Hitachi,
Japan). The density of myelinated fibers (MFs), axonal diam-
eter, myelin thickness, and the g-ratio ofMFs were determined
from semi-thin transverse sections using a computer-assisted
image analyzer (AnalySIS, Soft Imaging System, Germany).
Fig. 1 Pedigree, sequencing of C10orf2 gene mutations, and mtDNA
deletions in a Korean family. a Pedigree of family FC417.Open symbols
represent unaffected individuals and filled symbols affected individuals.
Proband is indicated by an arrow. Asterisks indicate individuals whose
DNAwas used for exome sequencing. C10orf2 sequences are indicated
below each family member. b Sequencing chromatograms of C10orf2
mutations. Vertical arrows indicate the mutation site. c Conservation of
the amino acid sequence in the p.T487I mutation region. The mutation
site is highly conserved among vertebrate species: H. sapiens,
NP_068602.2; M. musculus, NP_722491.2; R. norvegicus ,
NP_001101069.1; B. taurus, NP_001091933.1; M. mulatta,
NP_001181370.1; G. gallus, NP_001026515.1; P. paniscus,
XP_003825527.1; E. caballus, XP_001499990.1; F. catus ,
XP_003994378.1; and C. lupus familiaris, XP_003433659.1. d Identifi-
cation of a 4,977-bp common deletion in mtDNA. The 4,977-bp large
deletion (m.8470_13446del4977) was detected using the long template
PCR method. CTL(W), wild type; CTL(D), common deletion in adPEO;
II-2(B), DNA from the blood of patient II-2; II-2(T), DNA from the vastus
lateralis muscle; and M(1kb), 1-kb DNA ladder
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Magnetic resonance imaging (MRI) of the brain and lower
extremities
The brain, thigh, and lower leg of patients II-1 and II-2 were
evaluated by MRI using a 1.5-T system (Siemens Vision,
Siemens, Germany). Whole brains were scanned using a slice
thickness of 5 mm and a 2-mm interslice gap, to produce 16
axial images. The imaging protocol consisted of T2-weighted
spin echo (SE) (repetition time (TR)/echo time (TE)=4,700/
120 ms), T1-weighted SE (TR/TE=550/12 ms), and fluid-
attenuated inversion recovery (FLAIR) (TR/TE=9,000/
119 ms; inversion time=2,609 ms) images. Thigh and lower
leg (calf) muscle imaging was performed in axial [field of
view (FOV)=24–32 cm; slice thickness=6 mm; slice
gap=0.5–1.0 mm] and coronal planes (FOV=38–40 cm; slice
thickness=4–5 mm; slice gap=0.5–1.0 mm). The following
protocol was used: T1-weighted SE (TR/TE=570–650/14–
20, 512 matrixes), T2-weighted SE (TR/TE=2,800–4,000/
96–99; 512 matrixes), and fat-suppressed T2-weighted SE
(TR/TE=3,090–4,900/85–99, 512 matrixes).
Whole exome sequencing
Whole exome sequencing was performed for two individuals
(II-1 and II-2). Exome capture/enrichment of 44 Mb was
performed using the Human SeqCap EZ Human Exome Li-
brary v2.0 (Roche/NimbleGen, Madison, WI). Captured
DNA was amplified and sequenced on the Solexa GAIIx
(for II-1) and HiSeq2000 (II-2) Genome Analyzers (Illumina,
San Diego, CA). Paired-end sequences were mapped to the
reference human genome (GRCh37, UCSC hg19) using BWA
(http://bio-bwa.sourceforge.net/). The variant calling process
was run using SAMtools (http://samtools.sourceforge.net/).
For functional annotation and genetic filtering, variants were
submitted to ANNOVAR (http://www.openbioinformatics.
org/annovar/). Variants were filtered using exome data
from 35 Korean patients, including data from 29 CMT
patients [13, 14] and 6 deaf patients [15], along with
Korean-specific variants deposited in the TIARA data-
base [16]. To confirm candidate variants in additional
Korean controls, we used exome data from an additional
648 patient samples.
Capillary sequencing was performed to confirm candidate
variants. PCR products were sequenced using an ABI 3730
automatic genetic analyzer (Applied Biosystems, Foster City,
CA). Mutations were described according to the Human Ge-
nome Variant Society (HGVS) nomenclature (http://www.
hgvs.org/mutnomen) with nucleotide numbering based on
the mRNA sequence (NM_021830.4) of C10orf2 (http://
www.ncbi.nlm.nih.gov/nuccore/NM_021830). Segregation
analysis of mutations with disease phenotypes was
performed for all family members.
Mitochondrial DNA analysis
A deletion of 4,977 bp (m.8470_13446del4977) in
mtDNA, frequently referred to as the “common dele-
tion,” was tested in DNA extracted from whole blood
and the vastus lateralis muscle of patient II-2, using an
Expand Long Template PCR System (Roche, Germany).
PCR primers covered nucleotides 8,225–8,247 (forward)
and 13,707–13,729 (reverse) of the revised Cambridge
reference sequence (NC_012920.1).
Results
Identification of the novel mutation in the C10orf2 gene
We performed whole exome sequencing on an autosomal
recessive IOSCA family with sensorimotor polyneuropathy
and myopathy to identify mutations causally associated with
disease onset (Fig. 1a). Exome sequencing results of two
individuals are shown in Table 1. A total of 58,262 and
61,340 variants were identified in each of the two individuals,
respectively. Of these, a total of 10,714 and 9,543 variants
were identified as functionally significant, resulting in mis-
sense, nonsense, splice, or indel mutations. After filtering out
all dbSNP132 variants, we were able to reduce the numbers of
Table 1 Exome sequencing results for two affected individuals of family
FC417
Patients II-1 II-2
Mappable yield (bp) 5,206,019,945 5,937,912,039
On-target yield (bp) 3,248,319,559 3,393,707,908
% Coverage of targeted region
(44 Mb) >1×
97.9 % 97.0 %
% Coverage of targeted region
(44 Mb) >10×
94.0 % 90.9 %
Mean read depth of targeted region 73.8× 77.1×
Mean read depth of called variant ≥5× 58.9× 55.4×
Number of SNPs 50,733 53,119
Number of indels 7,529 8,221
Total variants 58,262 61,340




After dbSNP132 filtering 1,231 824
Shared variants between the
two individuals
365
After filtering with Korean control
exomesa
146
Genes with compound heterozygous
variants
2 (C10orf2 and LILRB1 genes)
a Exome data of 35 Koreans from other reports and the Korean genomes
database, TIARA
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functional variants to 1,231 and 824, respectively, with 365
variants shared between the two individuals. Additional filter-
ing was performed by excluding all variants identified in a
cohort of 35 Korean control exomes.
Based upon these analyses, we were able to identify com-
pound heterozygous variants in two genes, C10orf2 and leu-
kocyte immunoglobulin-like receptor, superfamily B (LILRB1)
(Table 1). We compared the four variants in C10orf2
(Chr10:102749617 and Chr10:102750192) and LILRB1
(Chr19:55143632 and Chr19:55145125) with those identified
in the 248 exome dataset. Only two variants in gene C10orf2
were absent from the 248 exome dataset (Supplementary
Table 1); these variants were also absent in a larger collection
of in-house exome data (n=400). We confirmed that both
C10orf2 heterozygous mutations c.1460C>T (p.T487I) and
c.1485-1G>A showed complete segregation with the disease
phenotype within the family (Fig. 1a, b). The patients’ father
carried a c.1485-1G>A splicing-site mutation, while the
mother carried the c.1460C>T missense mutation. The
p.T487I mutation was located at a highly conserved
location (Fig. 1c) and was predicted to be damaging,
according to in silico analyses using SIFT, PolyPhen-2,
and MUpro (Table 2). As several mutations in C10orf2
have been implicated in recessive IOSCA [6–8], we
therefore concluded that the two novel compound het-
erozygous mutations in C10orf2 described here were the
underlying cause of IOSCA in this family.
mtDNA deletion in muscle
As mutations in C10orf2 are associated with deletions
in mtDNA, we examined the mtDNA of patient 1 (II-2);
this revealed a large heteroplasmic common deletion of
4,977 bp (m.8470_13446del4977) in skeletal muscle,
whereas few or no deletions were identified in blood
mtDNA (Fig. 1d).
Clinical manifestations
The clinical features of patients with C10orf2 mutations are
described in Table 3. Patient II-2 (Fig. 2a, proband) was the
second child of healthy, non-consanguineous Korean parents.
He was born at full term, and the prenatal and neonatal history
was unremarkable. Early motor milestones were not signifi-
cantly delayed until 1 year of age, when his parents noticed
that he had become clumsy and spoke less often than before.
He was in a wheelchair by the age of 14 years. At age 17, we
performed MRI of the brain as the result of an ataxia. By
20 years of age, ataxia had become more severe, and a follow-
upMRI was performed. Neurological examination at 21 years
of age revealed severe distal muscle atrophy, pes cavus, and
scoliosis. Symptoms of ophthalmoplegia were not observed.
An ophthalmologist examined the patient, including dilated
fundus examination, and he confirmed that no optic atrophy
was present. Vibration and position senses were more severely
disturbed than pain and temperature senses. Deep tendon
reflexes were absent in all extremities. FDS and CMTNS
scores were 7 and 26, respectively, with both scores classify-
ing this patient as severely disabled. He also exhibited sub-
stantial intellectual disability, with an intelligence quotient
score of 54. A positron emission tomography (PET) scan of
patient II-2 showed decreased metabolic changes throughout
the brain. An echocardiogram was normal, and there was no
evidence of migraine, seizure, or psychiatric symptoms. An
electroencephalogram revealed a normal sleep record without
epileptiform discharges. Secondary sex characteristics were
well developed, with no signs of hypogonadism. His
blood lactate level was 17.0 μmol/L (reference interval
4.5–14.4 μmol/L), pyruvate level was 0.7 μmol/L (ref-
erence interval 0.3–0.9 μmol/L), and creatine kinase
level was 155 μmol/L (reference value <185 μmol/L),
all well within normal ranges. Liver transaminase levels
were normal: the AST level was 22 μ/L (reference
value <40 μ/L), and the alanine transaminase (ALT)
was 27 μ/L (reference value <40 μ/L).
Patient II-1 (Fig. 2) was the elder sister of patient II-2 and
was born at full term after an uneventful pregnancy. Early
motor milestones were not significantly delayed until
15 months, when her parents noticed that she had become
clumsy. She was first examined at 3 years of age due to ataxia
and athetoid movements; however, symptoms of
ophthalmoplegia were not observed. An ophthalmologist
examined the patient, and he confirmed that no optic
atrophy was present. A hearing deficit was found, and
by school age, she was completely deaf and began
communicating with sign language. She became
Table 2 C10orf2 heterozygous mutations associated with IOSCAwith sensorimotor polyneuropathy and myopathy
Gene Mutation In controls In silico analysis
Nucleotide Amino acid SIFT PolyPhen-2 MUpro
C10orf2 c.1460C>T p.T487I 0/648 0.02a 1.00a −0.566a
c.1485-1G>A Splicing acceptor 0/648 – – –
a Values indicate prediction of significant effect on protein structure or function
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wheelchair bound by the age of 14 years. When we
examined her at 23 years of age, she displayed muscle
weakness and atrophy of the bilateral distal muscles of
the upper and lower limbs. Loss of sensory and tendon
reflexes was similar to those of her younger brother.
FDS and CMTNS scores were 7 and 28, respectively,
both in the severe disability category. Pes cavus and
scoliosis were observed. Like her brother, she also ex-
hibited significant intellectual disability. An echocardio-
gram was normal, and there was no evidence of mi-
graine, seizure, or psychiatric symptoms. An electroen-
cephalogram revealed a normal sleep record without
epileptiform discharges. Secondary sex characteristics
were poorly developed, and she never menstruated.
Her lactate level was 41.0 μmol/L, pyruvate level was
0.9 μmol/L, and creatine kinase level was 71 μmol/L, all
within normal ranges. Liver transaminase levels were normal:
the AST level was 23 μ/L, and the ALT level was 38 μ/L. The
father (I-1, 50 years of age) and mother (I-2, 47 years of age)
were found to be normal by careful clinical and electrophys-
iological examinations.
Electrophysiological findings
The electrophysiological features of patients II-1 and II-2 are
described in Table 4. NCSs were performed three times, at
Table 3 Comparison of the clinical phenotypes of IOSCA patients with mutations in the C10orf2 gene
Patients (ethnicity) Korean English Finnish Turkish
Mutations [T487I]+[1485-1G>A] [P83S]+[R463W] [Y508C]+[Y508C], [Y508C]+[A318T] [L456V]+[L456V]
Number of patients 2 1 23 2
Onset age (years) >1 >1 >1 >1
Normal early milestones Yes Yes Yes Yes
Athetosis Yes Yes Yes Yes
Areflexia Yes Yes Yes Yes
Pes cavus Yes NA Yes Yes
Scoliosis Yes NA Yes NA
Hearing loss Yes NA Yes Yes
Psychomotor retardation Yes NA Yes Yes
Ophthalmoplegia No Yes Yes Yes
Liver involvement No No Yes No
Kidney involvement No No No No
Nerve conduction study Sensorimotor polyneuropathy Sensory neuropathy Sensory neuropathy Sensory neuropathy
Electromyography Abnormal Abnormal Abnormal Abnormal
Electroencephalography Normal Abnormal Abnormala Normal
mtDNA depletion NA NA Brain, liver NA
mtDNA deletion Yes NA No NA
Liver enzyme Normal Abnormalb Abnormalc Normal
Creatine kinase Normal NA Normal NA
Lactate Elevated Elevatedd Normal Normal
Pyruvate Normal NA Normal NA
Lactate/pyruvate ratio 45.6, 24.3 NA NA NA
Respiratory chain Normal Normal Normal NA
Brain MRI Abnormal Abnormal Abnormal Abnormal
Lower extremity MRI Abnormal NA NA NA
Muscle biopsy Myopathy, type grouping Type grouping Type grouping Type grouping
Nerve biopsy Axonal loss Axonal loss Axonal loss NA
References This study [7] [5, 10, 22, 23] [6]
NA not available
a Abnormal after epileptic encephalopathy
bWhen her symptoms worsen, liver enzymes were elevated
c Abnormal in patients with compound heterozygote mutation
d Inconsistently elevated in capillary lactate, while normal in CSF lactate
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19, 20, and 21 years of age for patient II-2, and at
22 years of age for patent II-1. MNCVs of the median,
ulnar, peroneal, and tibial nerves were all decreased. In
patient II-2, peroneal CMAPs were not elicited, and
tibial CMAPs were reduced. Sensory nerve action po-
tentials (SNAPs) of the median, ulnar, and sural nerves
were absent in both patients. The interval changes over
3 years in patient II-2 revealed slow disease progres-
sion. Needle EMG showed fibrillation and positive
sharp waves in the proximal and distal muscles. De-
layed visual evoked potentials and brainstem auditory
evoked potentials were decreased in both patients.
Muscle biopsy findings
Biopsy examination revealed variations in the size and
shape of fibers, characterized by small, scattered,
angulated degenerating myofibers (arrows), including
abnormal condensed NADH-tetrazolium-positive cells
(Fig. 3a, b). Electron microscopic examination con-
firmed the presence of degenerating myofibers with
diffusely scattered autophagic vacuoles, distorted myofi-
brillar arrangement, abnormal membranous structures,
and aggregated enlarged mitochondria with swelling,
concentric cristae, and dense inclusions (Fig. 3c, d).
ATPase reactions revealed groupings of both type 1
and type 2 myofibers across multiple pH concentrations
(Fig. 3e, f). No differences were seen following cyto-
chrome oxidase (Fig. 3g) or succinate dehydrogenase
(Fig. 3h) staining.
Nerve biopsy findings
Light microscopic examination of longitudinal and cross
sections of nerve fibers showed markedly decreased size
of nerve fascicles with marked subperineurial edema
and multifocal variable-sized Renaut bodies, which con-
sists of loose EMA-positive spindle cells. Semi-thin
transverse sections showed small MFs with almost com-
plete loss of large MFs (Fig. 4a). Remaining MFs
counted 5,101/mm2 (normal distal sural nerve in 21-
year-old male, 10,000/mm2). The range and average of
diameter of MFs were 1.50–10.13 and 3.87 μm, respec-
tively (The range and average of diameter of MFs in a
normal distal sural nerve of a 21-year-old male are 2.2–
14.2 and 5.4 μm, respectively). The histogram of diam-
eter sizes showed a unimodal distribution pattern;
19.5 % of the MFs had a diameter less than 3 μm,
Fig. 2 Images of patients II-2 (a
21 years of age) and II-1 (b
23 years of age). a Patient II-2
was unable to walk and has been
wheelchair-bound since 5 years of
age. Moderate-to-severe atrophies
of the lower limb muscles and
high-arched feet were evident. b
Patient II-1 was wheelchair-
bound by 7 years of age.
Atrophies of the lower leg and
hand muscles were prominent.
Substantial ankle joint
contractures and foot deformities
were also evident
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and 97.0 % had a diameter less than 6 μm (Fig. 4b).
The MF% area in this case was 6.46 % (normal sural
nerve of a 21-year-old male, 36.5 %). On electron
microscopic examination, the remaining small MFs
showed occasional excessive folding of myelin with
very rare evidence of regeneration (clusters of
regenerating fibers, small MFs with collars of Schwann
cell processes containing small unmyelinated axons,
mimicking a pseudo-onion bulb, or basal lamina onion
bulb formation) (Fig. 4c, d). Endoneurial fibroblast pro-
liferation and collagen deposition were evident.
Brain and lower extremity MRI findings
An MRI revealed hyperintense signal abnormalities in the
brains of both patients (Fig. 5). In patient II-1, high-signal-
intensity lesions of the bilateral middle cerebellar peduncles
were observed on T2-weighted images (Fig. 5a). In patient
II-2, similar lesions were not found at the age of
17 years (Fig. 5b); however, a follow-up study per-
formed 3 years later revealed bilateral symmetric high-
signal-intensity lesions in the middle cerebellar peduncle
(Fig. 5c), with a very similar appearance to those
Table 4 Electrophysiological features of IOSCA patients with compound heterozygous C10orf2 mutations
Patient II-1 Patient II-2 Normal value
Age at exam (years) 22 19 20 21
Side Rt Lt Rt Lt Rt Lt Rt Lt
Median nerve
TL (ms) 3.5 3.3 4.3 4.2 4.6 4.2 4.1 4.3 <3.9
CMAP (mV) 5.9 8.8 9.7 7.2 9.6 6.1 11.3 6.2 >6.0
MNCV (m/s) 48.9 48.9 48.1 47.9 47.3 42.9 47.2 43.6 >50.5
F-wave (ms) 29.6 29.0 34.0 32.8 34.6 35.2 36.6 33.6 <28.0
Ulnar nerve
TL (ms) 2.7 2.6 2.9 3.4 3.3 3.5 2.6 3.1 <3.0
CMAP (mV) 11.1 8.6 10.1 9.0 10.8 7.7 9.9 7.3 >8.0
MNCV (m/s) 48.9 47.8 49.0 47.2 45.5 43.1 45.5 45.5 >51.1
F-wave (ms) 30.0 29.2 32.8 33.0 34.6 35.0 37.4 34.2 <29.0
Peroneal nerve
TL (ms) 5.4 5.5 A A A A A A <5.3
CMAP (mV) 1.5 0.8 A A A A A A >1.6
MNCV (m/s) 37.4 36.6 A A A A A A >41.2
F-wave (ms) 52.2 73.8 A A A A A A <49.0
Tibial nerve
TL (ms) 2.8 3.3 7.2 5.0 4.2 4.4 4.2 4.5 <5.4
CMAP (mV) 2.7 3.9 1.5 1.1 1.3 1.0 0.8 1.0 >6.0
MNCV (m/s) 36.6 37.9 24.2 27.3 28.7 29.4 28.1 32.0 >41.1
F-wave (ms) 56.6 49.0 75.8 A 75.6 70.4 72.2 71.0 <52.1
Median sensory nerve
SNAP (μV) A A A A A A A A >8.8
SNCV (m/s) A A A A A A A A >39.3
Ulnar sensory nerve
SNAP (μV) A A A A A A A A >7.9
SNCV (m/s) A A A A A A A A >37.5
Sural nerve
SNAP (μV) A A A A A A A A >6.0
SNCV (m/s) A A A A A A A A >32.1
H-reflex (ms) A A A A A A A A <30.2
Bold characters indicate abnormal values. Normal conduction velocities: medianmotor nerve ≥50.5m/s; ulnar nerve ≥51.1m/s; and sural nerve ≥32.1 m/
s. Normal amplitudes: median motor nerve ≥6.0 mV; ulnar nerve ≥8.0 mV; and sural nerve ≥6.0 μV
A absent potentials, TL terminal latency,CMAP compound muscle action potential,MNCVmotor nerve conduction velocity, SNAP sensory nerve action
potential, SNCV sensory nerve conduction velocity, NP no potential
178 Neurogenetics (2014) 15:171–182
observed in patient II-1. Cerebellum and brainstem at-
rophy with prominent cerebellopontine cisternal spaces,
a widened fourth ventricle, and an enlarged cerebellar
cortical sulci were noted in both patients (Fig. 5d).
However, the cerebral hemisphere and basal ganglia
were normal in both patients, without evidence of atro-
phy or parenchymal changes.
Relatively intact muscle without abnormal signal
changes or muscle atrophy was observed in the thigh
(Fig. 6a, b); however, both patients exhibited hyperin-
tense signal abnormalities with muscle atrophy in the
calf (Fig. 6c, d). T1-weighted images demonstrated
muscle atrophy with signal changes in the superficial
posterior compartment, including the soleus and gastroc-
nemius muscles (arrows). Together, these findings
indicate that the distal muscles are impaired more se-
verely than the proximal muscles.
Discussion
Mutations in C10orf2 are associated with autosomal recessive
IOSCA, hepatocerebral syndrome, and adPEO. Mutations
cluster exclusively within the primase, linker, and helicase
domains, with the majority of recessive phenotypes occurring
as a result of mutations in the helicase domain [17]. In
accordance with this mode of action, the two patients
described here harbor novel compound heterozygous
mutations in the helicase domain (p.T487I and c.1485-
1G>A) resulting in phenotypes characteristic of IOSCA.
Fig. 3 Histopathological
characterization of the vastus
lateralis muscle (patient II-2). a–b
NADH-TR staining revealed a












concentric cristae, and dense
inclusions. e–f ATPase staining at
pH 9.4 revealed grouping of type
1 and type 2 myofibers. g
Cytochrome oxidase (COX)
staining did not show COX-
negative fibers. h Increased
succinate dehydrogenase staining
was not observed. Original
magnifications: a ×100; b ×200; c
×20,000; d ×40,000; e ×100; f
×100; g ×200; and h ×200
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Mutations adjacent to residue T487 have been associat-
ed with both dominant and recessive phenotypes: T405I,
L456V, R463W, and Y508 mutations cause IOSCA [6,
7, 18], while W474C, A475P, F478I, E479K, and
F485L cause PEO [19]. The C1485-1G>A mutation
may result in a shorter protein, thereby resembling
Twinky, a 582-amino-acid protein terminating with four
unique residues. Although this study contained a small
number of patients, the identified mutations were clearly
validated by Sanger sequencing as well as co-
segregation in the kindred (Fig. 1). In addition, neither
apparent causative mutation was identified in 648 Ko-
rean control samples (Table 2).
The Twinkle helicase protein, encoded by C10orf2, local-
izes to mitochondrial nucleoids and functions in collaboration
with DNA polymerase gamma. Mutations within this protein
negatively affect the integrity of mtDNA. Deletions of
mtDNA are typically associated with adPEO and have not
been reported in IOSCA patients [20, 21]. The identification
of mtDNA deletions in this study suggests that compound
mutations in the helicase domain affect C10orf2 activity in a
recessive manner.
Although a few IOSCA patients have been described
in Finland, only three cases have been reported else-
where, with no cases reported in Asian populations
[5–7, 10, 22, 23]. Axonal sensory neuropathy is thought
to be the most important pathological feature of IOSCA;
however, this report represents the first description of an
IOSCA patient harboring motor neuropathy. Before re-
ferral to our clinic, the two patients described in this
report were first diagnosed with hereditary motor and
sensory neuropathies (HMSN) due to sensory and motor
Fig. 4 Histopathological
characterization of distal sural
nerve biopsy (patient II-2). aGray
scale image of toluidine blue-
stained semi-thin transverse
sections revealing an absence of
large MFs, along with abundant
medium and small-sized MFs
(5,101/mm2). b Histogram
showing a unimodal distribution
pattern of MFs with diameter
<6 μm, representing 97.0 % of
total MFs. c–d Electron
micrographs revealed small MFs
with excessive folding of myelin
and rare axonal clusters. Original
magnifications: a ×400; c ×5,000;
and d ×12,000
Fig. 5 Brain MRI in patient II-1 (a) and patient II-2 (b–d). a High-
intensity lesions of the bilateral middle cerebellar peduncle (arrows) in
T2-weighted imaging (patient II-1; 20 years of age). bAt 17 years of age,
no high-intensity lesions were found in the middle cerebellar peduncle of
patient II-2. c However, a follow-up brain MRI 3 years later revealed
bilateral middle cerebellar peduncle lesions (arrows). d The bilateral
cerebellum and brainstem were atrophied, with prominent
cerebellopontine cisternal spaces, a widened fourth ventricle, and en-
larged cerebellar cortical sulci were observed in patient II-2 at 20 years
of age
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neuropathy and moderate to severe foot deformities
including high arches. Based upon these initial observa-
tions, we believe that the phenotypic spectrum of
IOSCA may be wider than reported previously. Screen-
ing patients for C10orf2 mutations may be beneficial for
patients with sensorimotor polyneuropathy, particularly
HMSN patients who present with symptoms of
spinocerebellar ataxia.
Histopathological analysis of the muscle biopsy revealed
myopathies harboring small, angulated, or elongated
degenerating myofibers containing aggregated, enlarged mi-
tochondria with concentric cristae. High ratios of lactate/
pyruvate were also observed. Although there was no evidence
of ragged red fibers by Gomori’s trichrome staining, or in-
creased SDH or NADH, the presence of scattered
degenerating myofibers with abnormal mitochondria suggests
an association with mtDNA deletions.
Brain MRI findings from both IOSCA patients revealed
high-intensity lesions of the middle cerebellar peduncles. In
patient II-2, no lesions were observed at 17 years of age;
however, clear bilateral cerebellar lesions were evident by age
20 years, consistent with observations of more severe ataxia.
These results suggest a correlation between the progression of
the clinical ataxia and the increasing severity of degenerative
IOSCA. Middle peduncular lesions may be useful as a prog-
nostic biomarker of IOSCA.MRI analysis of the lower extrem-
ities showed muscle atrophy with hyperintense signal changes
in the lower leg muscles of both patients. However, signal
intensities were normal in the thigh muscles, consistent with
the hypothesis of length-dependent axonal degeneration.
In conclusion, we identified novel compound heterozygous
mutations c.1460C>T (p.T487I) and c.1485-1G>A in
C10orf2 as the underlying cause of IOSCA combined with
sensorimotor polyneuropathy and myopathy. This study sug-
gests greater variability in the clinical spectrum of IOSCA
than reported previously and that screening of C10orf2 may
be helpful in diagnosing IOSCA, especially in patients
presenting with symptoms of axonal sensorimotor
polyneuropathy and myopathy.
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